Kaiser Permanente Washington Health Research Institute

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Kaiser Permanente美国19
2. Harvard University美国19
3. United States Food and Drug Administration美国15
4. University of Washington美国12
5. HealthPartners美国12
6. Centers for Disease Control and Prevention美国7
7. Brigham and Women's Hospital美国6
8. Marshfield Clinic Research Foundation美国6

按月发文

逐年被引

最新文献

1. 1
   Using Natural Language Processing of Clinical Notes to Supplement Structured Electronic Health Record Data for Phenotyping Smoking and Obesity in a Healthcare SystemPharmacoepidemiology and Drug Safety20261
2. 2
   Identifying COVID ‐19 Disease Severity in Real‐World Data: Implications for Medical Product Effectiveness StudiesPharmacoepidemiology and Drug Safety20260
3. 3
   A Systematic Process for Assessing Fitness‐for‐Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record DataPharmacoepidemiology and Drug Safety20261
4. 4
   Psychiatric Medication Adherence in the United States Before and During the COVID ‐19 PandemicPharmacoepidemiology and Drug Safety20252
5. 5
   Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient ClaimsPharmacoepidemiology and Drug Safety20251
6. 6
   The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )Pharmacoepidemiology and Drug Safety202428
7. 7
   Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID ‐19 Vaccines Among Adults in the Vaccine Safety DatalinkPharmacoepidemiology and Drug Safety20243
8. 8
   Variation in completeness of coding external cause of injuries under ICD-10-CMInjury Prevention20244
9. 9
   Predicting risk of suicidal behavior from insurance claims data vs. linked data from insurance claims and electronic health recordsPharmacoepidemiology and Drug Safety20236
10. 10
    Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypesPharmacoepidemiology and Drug Safety202217

高被引文献

1. 1
   Validation of diagnosis codes to identify hospitalized COVID ‐19 patients in health care claims dataPharmacoepidemiology and Drug Safety202153
2. 2
   Identification of Stevens–Johnson syndrome and toxic epidermal necrolysis in electronic health record databasesPharmacoepidemiology and Drug Safety201551
3. 3
   Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community settingPharmacoepidemiology and Drug Safety201546
4. 4
   Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasonsPharmacoepidemiology and Drug Safety201642
5. 5
   Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomaliesPharmacoepidemiology and Drug Safety201535
6. 6
   Inflation of type I error rates due to differential misclassification in EHR‐derived outcomes: Empirical illustration using breast cancer recurrencePharmacoepidemiology and Drug Safety201833
7. 7
   Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapyPharmacoepidemiology and Drug Safety202030
8. 8
   Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesPharmacoepidemiology and Drug Safety202129
9. 9
   Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome associationPharmacoepidemiology and Drug Safety201629
10. 10
    The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )Pharmacoepidemiology and Drug Safety202428

主要发表期刊